Last reviewed · How we verify
Placebo of Lyrica — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Lyrica (Placebo of Lyrica) — KunWha Pharmaceutical Co., Ltd.. This is a placebo control formulation used in clinical trials to compare against the active drug Lyrica (pregabalin).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Lyrica TARGET | Placebo of Lyrica | KunWha Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Lyrica CI watch — RSS
- Placebo of Lyrica CI watch — Atom
- Placebo of Lyrica CI watch — JSON
- Placebo of Lyrica alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Lyrica — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-lyrica. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab